ACE BioSciences Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

ACE BioSciences General Information

Description

Developer of antibacterial drugs. The company is focused on developing novel vaccines for the prevention and treatment of bacterial infections, diarrhea, pneumococcal infections, cancer and streptococcus pneumonia..

Contact Information

Website
www.acebiosciences.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Unsbjergvej 2A
  • 5220 Odense
  • Denmark
Primary Industry
Pharmaceuticals
Acquirer
Zymenex
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Unsbjergvej 2A
  • 5220 Odense
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACE BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Nov-2009 Completed Generating Revenue
2. Later Stage VC 19-Dec-2007 Completed Generating Revenue
1. Early Stage VC $33.7M $33.7M Completed Startup
To view ACE BioSciences’s complete valuation and funding history, request access »

ACE BioSciences Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BankInvest Biotech Ventures Venture Capital Minority
Dansk Erhvervsinvestering Venture Capital Minority
Heartcore Capital Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
To view ACE BioSciences’s complete investors history, request access »

Ready to get started?

Request a free trial

ACE BioSciences FAQs

  • When was ACE BioSciences founded?

    ACE BioSciences was founded in 2001.

  • Where is ACE BioSciences headquartered?

    ACE BioSciences is headquartered in Odense, Denmark.

  • What industry is ACE BioSciences in?

    ACE BioSciences’s primary industry is Pharmaceuticals.

  • Is ACE BioSciences a private or public company?

    ACE BioSciences is a Private company.

  • What is ACE BioSciences’s current revenue?

    The current revenue for ACE BioSciences is .

  • How much funding has ACE BioSciences raised over time?

    ACE BioSciences has raised $51.1M.

  • Who are ACE BioSciences’s investors?

    BankInvest Biotech Ventures, Dansk Erhvervsinvestering, Heartcore Capital, and Sunstone Life Science Ventures have invested in ACE BioSciences.

  • When was ACE BioSciences acquired?

    ACE BioSciences was acquired on 09-Nov-2009.

  • Who acquired ACE BioSciences?

    ACE BioSciences was acquired by Zymenex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process